arrow
返回
H

Hee Kyung Ahn

sungkyunkwan university (skku)

34H指数
287论文数
4.1K被引数
收录论文 66
发表时间
err分享
err收藏
Genomic and transcriptomic analyses of residual invasive triple-negative breast cancer after neoadjuvant chemotherapy in the prospective MIRINAE trial (a randomized phase II trial of adjuvant atezolizumab plus capecitabine compared to capecitabine; KCSG-BR18-21)MIRINAE试验(一项比较辅助阿替利珠单抗联合卡培他滨与单用卡培他滨的随机II期试验;KCSG-BR18-21)中,新辅助化疗后残留浸润性三阴性乳腺癌的基因组学和转录组学分析
err2025-09-24
err0
PREAI
errS.-A. Im; K. Park; J. Koh; C. Park; K.H. Jung; J. Lee; H.K. Ahn; A. Lee; S.H. Sim; M.H. Kim; J.H. Kim; J.H. Kim; K.E. Lee; K.H. Park; J. Bae; M.H. Lee; S. Lim; H.J. Kim; D.-W. Lee; J.H. Jeong; K.S. Lee; J. Sohn; K.J. Suh; J.-Y. Kim; Y.J. Cha; J. Moon; C.-Y. Ock; S.-B. Kim; K. Shin; H. Chae; G.M. Kim; K.-H. Lee; W.-Y. Park; Y.H. Park; I.H. Park
err分享
err收藏
Identifying predictive markers of head and neck squamous cell carcinoma in an umbrella trial (KCSG HN 15-16 TRIUMPH trial)在伞形试验(KCSG HN 15-16 TRIUMPH试验)中识别头颈鳞状细胞癌的预测性生物标志物
err2025-09-17
err0
PREAI
errS. Hwang; M.H. Hong; S.H. Shin; T. Yun; K.-W. Lee; J.H. Kim; M.J. Ahn; B. Keam; H.W. Lee; M.K. Kim; H.J. Yun; Y. Kim; H.J. Kim; S.H. Cho; H.J. An; S.Y. Oh; S.-G. Park; Y.W. Koh; H.K. Ahn; J.H. Kwon; Y.-G. Lee; K.-U. Park; I.G. Hwang; S.-B. Kim; S. Kim; H.R. Kim
err分享
err收藏
Efficacy and Safety of a 3-Weekly TS-1 Adjuvant Regimen in Advanced Gastric Cancer: A Pilot Study3周方案TS-1辅助疗法在晚期胃癌中的疗效与安全性:一项初步研究
err2025-07-31
err0
errOAAI
errJihong Bae; Joo-Hwan Park; Young Saing Kim; Hee Kyung Ahn; Eun Kyung Cho; Dong Bok Shin; Ji-Hyeon Park; Jun-Young Yang; Woon Kee Lee; Sun Jin Sym
err分享
err收藏
Real-world evidence of the efficacy of neoadjuvant pembrolizumab in triple-negative breast cancer: A surgeon's point of view
errEJSO
IF2.9
err2025-07-03
err0
PREAI
errPark, Woong Ki; Nam, Seok Jin; Kim, Seok Won; Yu, Jonghan; Lee, Se Kyung; Ryu, Jai Min; Chae, Byung Joo; Shin, Dong Seung; Ahn, Jin Seok; Park, Yeon Hee; Kim, Ji-Yeon; Shin, Junghoon; Ahn, Hee Kyung; Cho, Eun Yoon; Lee, Hyunwoo; Lee, Jeong Eon
err分享
err收藏
Scalp cooling for preventing persistent chemotherapy-induced alopecia in anthracycline-treated patients: A single-arm trial头皮冷却预防蒽环类药物治疗患者持续性化疗诱导脱发:一项单臂试验
err2025-06-16
err0
PREAI
errDanbee Kang; Haseen Lee; Di Zhao; Nayeon Kim; Hoyoung Kim; Sooyeon Kim; Ji-Yeon Kim; Yeon Hee Park; Hee-Kyung Ahn; Eliseo Guallar; Juhee Cho; Jin Seok Ahn
err分享
err收藏
Lazertinib for Patients with NSCLC Harboring Uncommon EGFR Mutations: A Phase II Multicenter TrialLazertinib治疗不常见EGFR突变的NSCLC患者: 一项II期多中心试验
err2025-05-09
err0
errOAAI
errSehhoon Park; Hee Kyung Ahn; Seoyoung Lee; Young Joo Min; Jinyong Kim; Hyun Ae Jung; Jong-Mu Sun; Se-Hoon Lee; Jin Seok Ahn; Myung-Ju Ahn; Jii Bum Lee; Sun Min Lim; Hye Ryun Kim; Byoung Chul Cho; Min Hee Hong
err分享
err收藏
A phase II study of tepotinib in patients with advanced solid cancers harboring MET exon 14 skipping mutations or amplification (KCSG AL19-17) (vol 9, 103668, 2024)一项关于 tepotinib 在携带 MET 外显子 14 跳跃突变或扩增的晚期实体癌患者中的 II 期研究 (KCSG AL19-17) (第 9 卷,103668,2024)
err2025-04-01
err0
PREAI
errKang, E. J.; Yang, Y.; Lee, S.; Kim, Y. J.; Lim, S. M.; Ahn, M. -j.; Choi, Y. J.; Lee, Y.; Kim, T. M.; Kim, I.; Ahn, H. K.; Jeung, H. -c.; Lee, S. I.; Oh, S. Y.; Bae, W. K.; Ryu, H.; Park, K. H.; Lee, K. H.
err分享
err收藏
Pharmacokinetics, safety, and efficacy of an alternative dosing regimen of sasanlimab in participants with advanced NSCLC and other malignancies
err2024-09-11
err0
errOAAI
errPenkov, Konstantin; Bondarenko, Igor; Saenko, Daria Viktorovna; Kulyaba, Yaroslav; Guo, Jun; Gong, Yi; Yamamoto, Noboru; Hotko, Yevhen Stepanovych; Boyko, Vasyl; Fadeeva, Natalya Vladimirovna; Ursol, Grygorii Mykolaiovych; Ahn, Hee Kyung; Kislov, Nikolay Viktorovich; Shen, Chia-, I; Davis, Craig; Kowalski, Karey; Michelon, Elisabete; Pavlov, Dmitri; Hirohashi, Tomoko; Cho, Byoung Chul
err分享
err收藏
Lazertinib for patients with NSCLC harboring uncommon EGFR mutations: A single-arm, phase II multi-center trial拉泽替尼用于携带少见EGFR突变非小细胞肺癌患者的治疗:一项单臂、II期多中心试验
err2024-09-01
err0
PREAI
errPark, S.; Ahn, H. K.; Lee, S.; Min, Y. J.; Jung, H. A.; Sun, J-M.; Lee, S-H.; Ahn, J. S.; Ahn, M-J.; Lee, J. B.; Lim, S. M.; Kim, H. R.; Cho, B. C.; Hong, M. H.
err分享
err收藏
A phase II study of tepotinib in patients with advanced solid cancers harboring MET exon 14 skipping mutations or amplification (KCSG AL19-17)tepotinib在患有MET外显子14跳跃突变或扩增的晚期实体癌患者中的II期研究 (KCSG AL19-17)
err2024-09-01
err0
errOAAI
errKang, E. J.; Yang, Y.; Lee, S.; Kim, Y. J.; Lim, S. M.; Ahn, M. -J; Choi, Y. J.; Lee, Y.; Kim, T. M.; Kim, I.; Ahn, H. K.; Jeung, H. -C; Lee, S. I.; Oh, S. Y.; Bae, W. K.; Ryu, H.; Park, K. H.; Lee, K. H.
err分享
err收藏
Comparison of clinical efficacy between letrozole plus ribociclib vs. Fulvestrant plus letrozole plus ribociclib in Hormone receptor positive, HER2 negative metastatic breast cancer - a randomized, phase 2 study (KCSG BR22-20)
err2024-05-02
err0
PREAI
errLee, Jieun; Koh, Su-Jin; Kwon, Jung Hye; Kim, Gun Min; Kim, Jee Hung; Kim, Ho Young; Kim, Hee-Jun; Park, Keon-Uk; Park, Kyong Hwa; Park, Yeon Hee; Ahn, Mi Sun; Ahn, Hee Kyung; Lee, Gyeong-Won; Lee, Kyoung Eun; Lee, Kyung-Hun; Lee, Moon Hee; Lee, Sung Sook; Lee, Jung Lim; Jung, Kyung Hae; Jung, Joo Young; Park, In Hae
err分享
err收藏
Randomized phase II study of talazoparib vs talazoparib plus atezolizumab for patients with premenopausal HR+/HER2-metastatic breast cancer harboring homologous recombination deficiency scar (Young-PALETTA, KCSG BR21-09)
err2024-05-02
err0
PREAI
errAhn, Hee Kyung; Lee, Jieun; Kim, Jee Hung; Lee, Kyung-Hun; Kim, Jee Hyun; Kim, Min Hwan; Kwon, Minsuk; Kim, Han Jo; Jung, Kyung Hae; Park, Yeon Hee
err分享
err收藏
Impact of PIK3CA and cell cycle pathway genetic alterations on durvalumab efficacy in patients with head and neck squamous cell carcinoma: Post hoc analysis of TRIUMPH study
err2024-04-01
err3
PREAI
errKim, Dong Hyun; Lim, Seung Taek; Kim, Hye Ryun; Kang, Eun Joo; Ahn, Hee Kyung; Lee, Yun- Gyoo; Sun, Der Sheng; Kwon, Jung Hye; Lee, Sang-Cheol; Lee, Hyun Woo; Kim, Min Kyoung; Keam, Bhumsuk; Park, Keon-Uk; Shin, Seong-Hoon; Yun, Hwan Jung
err分享
err收藏
A nationwide real-world study for evaluation of effectiveness and safety of T-DM1 in patients with HER2-positive metastatic breast cancer in Korea (KCSG BR19-15)
err2024-01-28
err0
errOAAI
errBaek, Sun Kyung; Jeong, Jae-ho; Jung, Kyunghae; Ahn, Hee Kyung; Kim, Min Hwan; Sohn, Joohyuk; Park, In Hae; Ahn, Jin Seok; Lee, Dae-Won; Im, Seock-Ah; Sim, Sung Hoon; Lee, Keun Seok; Hyun Kim, Jee; Shim, Hyun-Jeong; Chae, Yeesoo; Koh, Su-Jin; Lee, Hyorak; Lee, Jieun; Byun, Jae-Ho; Seol, Youngmi; Lee, Eun Mi; Jee, Hee-Jung; An, Hyonggin; Park, Eun Byeol; Suh, Young Ju; Lee, Kyoung Eun; Park, Yeon Hee
err分享
err收藏
Cerebrospinal fluid pharmacokinetic study of lazertinib and pemetrexed in patients with EGFR-mutant non-small cell lung cancer with leptomeningeal metastases: KCSG21-01 LAZARUS trial
err2023-10-01
err0
errOAAI
errKeam, B.; Jung, H. A.; Kim, T. M.; Kim, H. R.; Kim, C. G.; Ahn, H.; Lee, Y.; Kim, Y. J.; Kim, M.; Youk, J.; Sun, J-M.; Lee, S-H.; Ahn, J. S.; Kim, D-W.; Ahn, M-J.
err分享
err收藏
A phase Ib/II dose expansion study of subcutaneous sasanlimab in patients with locally advanced or metastatic non-small-cell lung cancer and urothelial carcinoma
err2023-08-01
err5
errOAAI
errCho, B. C.; Penkov, K.; Bondarenko, I.; Kurochkin, A.; Pikiel, J.; Ahn, H. K.; Korozan, M. E.; Osipov, M.; Odintsova, S.; Braiteh, F.; Ribas, A.; Grilley-Olson, J. E.; Lugowska, I.; Bonato, V.; Damore, M. A.; Yang, W.; Jacobs, I. A.; Bowers, M.; Li, M.; Johnson, M. L.
err分享
err收藏